How to Reconstitute Tirzepatide: Step-by-Step Visual Guide

Materials Needed

Gather the following before beginning: lyophilized tirzepatide vial (commonly 5 mg, 10 mg, or 15 mg), bacteriostatic water vial (30 mL), insulin syringes (U-100, 1 mL, 29–31 gauge), alcohol prep pads, exam gloves, and a sharps container. Work on a clean, flat surface. Tirzepatide is a dual GIP/GLP-1 receptor agonist; preclinical research uses involve metabolic and body composition endpoints. Approved formulations (Zepbound, Mounjaro) are pre-mixed by the manufacturer — this guide covers research-grade lyophilized tirzepatide only.

Calculating BAC Water Volume

Target concentration determines how many units on the syringe correspond to each dose. For a 10 mg vial targeting a concentration of 2 mg/mL: 10 mg ÷ 2 mg/mL = 5 mL BAC water. This yields 2 mg (2,000 mcg) per mL, or 2,000 mcg per 100 units on a U-100 syringe.

Alternative for a 5 mg vial targeting 1 mg/mL: 5 mg ÷ 1 mg/mL = 5 mL BAC water. This yields 1 mg per mL = 1,000 mcg per 100 units on the syringe.

Reconstitution Steps

Step 1 — Swab both vial stoppers with alcohol pads. Allow to air-dry 30 seconds.

Step 2 — Draw the calculated BAC water volume into the syringe from the BAC water vial. For large volumes (e.g., 5 mL), use multiple syringe fills with a 1 mL syringe.

Step 3 — Insert needle into the tirzepatide vial and slowly inject BAC water along the inner vial wall. Do not aim directly at the powder cake.

Step 4 — Gently swirl the vial in slow circles until the powder is fully dissolved. The solution should be clear and colorless. Do not shake.

Step 5 — Inspect for clarity and absence of particulates before drawing into delivery syringe.

Calculating Units on Syringe per Dose

Using a 10 mg vial reconstituted to 5 mL (2 mg/mL = 2,000 mcg/mL):

2.5 mg dose: 2,500 mcg ÷ 2,000 mcg/mL = 1.25 mL. With a 1 mL syringe this requires 1 full syringe (100 units) + 25 units in a second draw.

5 mg dose: 5,000 mcg ÷ 2,000 mcg/mL = 2.5 mL = two full 1 mL syringes + 50 units.

For easier math, use 1 mg/mL (5 mg in 5 mL). Then: 2.5 mg = 250 units (2.5 mL); 5 mg = 500 units (5 mL). A 0.5 mL (50-unit) syringe draw = 500 mcg at this concentration.

Storage After Reconstitution

Store reconstituted tirzepatide at 2–8°C. When reconstituted in bacteriostatic water, stability is approximately 4–6 weeks under refrigeration. Do not freeze. Label with reconstitution date and concentration. Per FDA labeling for approved tirzepatide formulations (Zepbound, Mounjaro), the active ingredient requires refrigerated storage; extrapolating from this, research-grade solutions should be similarly handled.

Safety Notes and Research Framing

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is FDA-approved as Zepbound (obesity) and Mounjaro (type 2 diabetes). Research-grade lyophilized tirzepatide is used in preclinical metabolic research. All reconstitution described here applies solely to research contexts. This guide does not constitute medical or clinical advice.